Our study revealed that CETN2 and POFUT1 autoantibodies have potential clinical diagnostic value for early ESCC and precancerous lesions, and the detection of serum autoantibodies of CETN2 and POFUT1 can improve the diagnostic rate of early ESCC. The gene discussed is CETN2; the disease is esophageal squamous cell carcinoma.